ECHAMP, the European Coalition on Homeopathic and Anthroposophic Medicinal Products, represents an EU-based industry that has been serving the European market for decades. EU legislation for homeopathic medicinal products has deep roots in their broad use in the Member States; the EU being the global centre of expertise in manufacturing, quality standards and regulation of this industry.
ECHAMP
Industry association · Belgium · EU Transparency Register 85825114058-57
Counts here are a floor, never a total: they cover the 583 consultation files tracked so far (42,224 submissions, mostly 2025–26), so an organization's real filing history is larger, not smaller.
Who they are
Among the 1365 trade and business associations on this site, they rank #631 by legislative files engaged — a count of participation, not a measure of influence.
Declares membership of
- ECHAMP has about 37 company members from 15 EU Member States plus Norway (Full Members) and 4 Extraordinary Partners…
Self-declared to the EU Transparency Register (snapshot 2 Sept 2026).
- Register category
- Trade and business associations
- Registered as
- European Coalition on Homeopathic and Anthroposophic Medicinal Products (ECHAMP)
- Head office
- Brussels, Belgium
Self-declared to the EU Transparency Register (snapshot 2 Sept 2026); cost bands are floors, not audited totals. Reused under Commission Decision 2011/833/EU.
Track ECHAMP in PolicySpeak: request access →
Work at ECHAMP? so we know who speaks for it.
Their record over time
ECHAMP filed 5 positions between 16 Oct 2019 and 23 Oct 2023, across 3 of the 583 legislative files tracked here, attaching a full position paper 1 time.
What they argued
ECHAMP, the European Coalition on Homeopathic and Anthroposophic Medicinal Products, represents an EU-based industry that has been serving the European market for decades. EU legislation for homeopathic medicinal products has deep roots in their broad use in the Member States; the EU being the global centre of expertise in manufacturing, quality standards and regulation of this industry.
ECHAMP, the European Coalition on Homeopathic & Anthroposophic Medicinal Products, represents the majority of the companies active in the production and distribution of those products in the EU. We endorse the rights of more than 110 million patients and consumers in the EU to have easy and comprehensive access to reliable homeopathic and anthroposophic medicinal products which meet the highest standards of quality…
ECHAMP welcomes and supports this important initiative, which will be an essential cornerstone for the Pharmaceutical Strategy. We are pleased to see that the proposal emphasizes the importance of allowing patients and citizens control over their own health data and of exploring how to facilitate the inclusion of citizen-generated data.
ECHAMP welcomes this consultation and we are pleased that possible misalignment of some fees with the underlying costs will be addressed. We fully support the objective of ensuring a fair distribution of fees. We ask for your specific attention for the category of homeopathic medicinal products.
Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.
Put ECHAMP next to another organization. Same files, same register facts, side by side. Compare →
Turns up on the same files
Organizations that also filed on at least two of the same consultations. A shared interest in the same dossiers — not evidence of coordination, and we do not suggest any.
Showing 5 of 61.
Is this your organization?
Everything on this page comes from ECHAMP’s own submissions to the European Commission — we have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.
Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.